Human growth hormone treatment for adult growth hormone deficiency a review of the clinical effectiveness, safety, cost-effectiveness, and guidelines
The purpose of this report is to retrieve and review the existing evidence of clinical effectiveness, safety, and cost-effectiveness of human growth hormone replacement (GHR) therapy in patients with severe growth hormone deficiency (GHD) due to pituitary destruction 25 years of age and older. This...
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Ottowa, Ont.]
CADTH Rapid Response Service
13 March 2015, 2015
|
| Series: | Rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | The purpose of this report is to retrieve and review the existing evidence of clinical effectiveness, safety, and cost-effectiveness of human growth hormone replacement (GHR) therapy in patients with severe growth hormone deficiency (GHD) due to pituitary destruction 25 years of age and older. This report also aims to retrieve and review existing guidelines for GHD due to pituitary destruction in patients 25 years of age and older. The final purpose of this report is to retrieve and review GHR therapy guidelines for pediatric GHD patients who have attained final adult height |
|---|---|
| Physical Description: | 1 PDF file (39 pages) illustration |